Chemical Diversity Research Institute

Recent papers from Chemical Diversity Research Institute

1. Acute Perinatal Hypoxia Impairs Neurobehavioral Development and Increases Basilar Artery Contractility in Adult Male RatsInternational Journal of Molecular Sciences · 2026
2. Punctal and Intracanalicular Drug Delivery Systems for Ophthalmic Use: A Narrative Review of Technologies, Clinical Outcomes, and Critical Quality AttributesPharmaceutics · 2026
3. Prolonged Infections and Inflammatory Diseases in Common Variable Immune Deficiency as a Cause of AA AmyloidosisJournal of Clinical Medicine · 2026
4. Lysimachia × glabrophora (Ericales, Primulaceae), a new wild nothospecies from the Republic of KoreaZooKeys · 2026
5. The role of the CNTNAP2 gene in the development of autism spectrum disorderResearch in autism spectrum disorders · 2024
6. Efficacy and safety of Aviandr in the treatment of anxiety in patients with adjustment disorders after COVID-19S S Korsakov Journal of Neurology and Psychiatry · 2024
7. The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmiaRussian Annals of Ophthalmology · 2024
8. Asymmetric Metal‐Templated Approach to Amino Acids with a CF3‐Containing 3,2’‐Pyrrolidinyl Spirooxindole Core via a Michael/Mannich [3+2]‐Cycloaddition ReactionAdvanced Synthesis & Catalysis · 2023
9. Analysis of the Structural Transformations Underlying the Design of Innovative Next-in-Class DrugsRussian Journal of General Chemistry · 2023
10. Determination of Fire Blight Susceptibility on Wild Rosaceae Plants in Korea by Artificial InoculationResearch in Plant Disease · 2023
11. Antituberculosis Macozinone Extended-Release Tablets To Enhance Bioavailability: a Pilot Pharmacokinetic Study in Beagle DogsMicrobiology Spectrum · 2022
12. Synthesis of New Isoquinoline Derivatives from the Condensation Products of Acid Anhydrides and 2-(3,4-Dimethoxyphenyl)ethanamineRussian Journal of Organic Chemistry · 2022
13. Asymmetric Metal‐Templated Route to Amino Acids with 3‐Spiropyrrolidine Oxindole Core via a 1,3‐Dipolar Addition of Azomethine Ylides to a Chiral Dehydroalanine Ni(II) ComplexAdvanced Synthesis & Catalysis · 2022
14. Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodiumActa Crystallographica Section E Crystallographic Communications · 2021
15. Comparative morphological and biochemical characteristics of the toxic effects of doxorubicin and nanosomal PLGA-doxorubicin form in the experimental glioblastoma treatmentCLINICAL AND EXPERIMENTAL MORPHOLOGY · 2021
16. Aprotinin is a potent multi-target drug for the combination therapy of moderate COVID-19 cases2020
17. Aprotinin ‐ a new multi-target drug candidate or "magic shotgun" for the therapy of COVID‐192020
18. Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking StudiesMolecules · 2020
19. Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19)2020
20. AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical TrialClinical Infectious Diseases · 2020